Category: Life Sciences
Global Life Sciences
-
Nanobiotechnology
... 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the ... Read More
-
Stem Cell Services
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market in the U.S. ... Read More
-
Gynecological Surgical Devices
... at a CAGR of 2.8% over the analysis period 2024-2030. Female Sterilization & Contraceptive Devices, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$9.3 Billion by ... Read More
-
Medical Transcription Services
... at a CAGR of 5.7% over the analysis period 2024-2030. Consultation Reports, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$45.6 Billion by the end of ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Antimicrobial Coatings
... CAGR of 8.1% over the analysis period 2024-2030. Silver Coatings, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More
-
Breast Cancer Therapeutics
... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More
-
Organ and Tissue Transplantation
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Tissue Products, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$20.5 Billion by the ... Read More
-
Breath Analyzers
... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells Technology, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Tissue Banking Equipment and Consumables
... Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Tissue Banking Consumables, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$2.5 ... Read More
-
Transfection Technologies
... CAGR of 7.3% over the analysis period 2024-2030. Protein Production Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$694.1 Million by the end of the ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Vascular Stents
... CAGR of 4.3% over the analysis period 2024-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis ... Read More
-
Veterinary Chemistry Analyzers
... at a CAGR of 4.4% over the analysis period 2024-2030. Veterinary Chemistry Analyzer Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$898.8 Million by the ... Read More
-
Wireless Portable Medical Devices
... 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Monitoring Application, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$19.8 Billion by the ... Read More
-
X-Ray Crystallography
... CAGR of 11.4% over the analysis period 2024-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$944.5 Million by the end of the analysis ... Read More
-
Dental Diagnostic Imaging Equipment
... 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Intraoral Imaging Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by ... Read More
-
Psychiatric and Substance Abuse Hospitals
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.5 ... Read More
-
Up-Regulated Protein
... CAGR of 6.2% over the analysis period 2024-2030. Diagnostic Labs End-Use, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$300.9 Million by the end of the ... Read More
-
Laboratory Vacuum Pumps
... at a CAGR of 5.3% over the analysis period 2024-2030. Dry Vacuum Pumps, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.6 Billion by the end ... Read More
-
Oral Solid Dosage Forms (OSDF) and Pharma Excipients
... 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth ... Read More
-
Automotive Micro Switch
... at a CAGR of 3.9% over the analysis period 2024-2030. Standard Micro Switches, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$922.8 Million by the end ... Read More
-
Biotech Flavors
... CAGR of 6.7% over the analysis period 2024-2030. Vanilla & Vanillin Flavors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$872.9 Million by the end of ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
Research Assistance
